
Welcome to TORC
Setting the benchmark in clinical research.

About Us
At TORC, we blend innovation with expertise.
Our human-centric approach to advanced solutions offers flexibility in designing customized solutions that seamlessly translate digital imaging into reliable data.
Committed to integrity and exactness, our secure platforms and expert assessors transform images into actionable insights. Our meticulous approach delivers outcomes and endpoints of clarity and precision, setting new standards in clinical research.
More About Us
01
Advanced
At TORC, advancement is more than a goal—it's a commitment. We continuously harness cutting-edge technologies and methodologies to ensure our solutions stand at the forefront of clinical research, driving progress and innovation in every endeavor.
02
Exact
Precision is the cornerstone of our approach. TORC's dedication to exactness ensures that every data point, solution, and outcome is delivered with unparalleled accuracy. We believe that clarity in detail lays the foundation for impactful results.
03
Secure
We pride ourselves on our established track record and unwavering commitment to reliability. With years of seasoned experience, we employ rigorous measures and best practices to ensure data integrity and confidentiality.
04
Human-Centric
Behind every project, data point, and solution, lies the human element. TORC's human-centric approach prioritizes understanding and collaboration. We believe in crafting solutions that resonate, ensuring research outcomes are both impactful and personal.
05
Flexible
In the dynamic realm of clinical research, adaptability is key. TORC prides itself on its flexible approach, tailoring solutions to meet evolving needs and challenges. Our agility ensures we remain responsive, proactive, and always aligned with our partners' objectives.

Our Partners




Leadership Team
Founded by Dr. Shoaib Ugradar, TORC's team boasts an extensive twenty-year involvement in Thyroid Eye Disease (TED) research. Together, TORC founders were among the pioneering groups to recognize the therapeutic potential of IGF-1R therapy for TED.
Today, our proprietary technology is integral to several significant trials in collaboration with leading organizations such as Horizon Therapeutics, Viridian Therapeutics, and Valenza Bio. Our methodologies and findings have been recognized through over 20 peer-reviewed publications spanning the fields of ophthalmology and endocrinology, reflecting our dedication to advancing scientific knowledge in the domain.
Contact Us
Elevate your clinical research with tailored solutions,
Discover where innovation meets integrity, and experience the TORC difference.
